J Gynecol Oncol.
2019 Nov;30(6):e111. 10.3802/jgo.2019.30.e111.
Comments on: Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: a prospective study
- Affiliations
-
- 1Department of Surgery, Federal University of Pernambuco-UFPE, Recife, Brazil. t.paulo@outlook.com
- 2Department of Surgery/Oncology, Instituto de Medicina Integral Professor Fernando Figueira-IMIP, Recife, Brazil.
- 3Peritoneal Surface Malignancies unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy.
- KMID: 2458907
- DOI: http://doi.org/10.3802/jgo.2019.30.e111
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: a prospective study
- An overview of the current debate between using minimally invasive surgery versus laparotomy for interval cytoreductive surgery in epithelial ovarian cancer
- A case of advanced ovarian cancer which was treated with topotecan after taxol-cisplatin treatment failed
- The Response Rate of Carboplatin/Paclitaxel for the Platinum Sensitive Recurrent Ovarian Cancer Patients
- Effect of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on relapse pattern in primary epithelial ovarian cancer: a propensity score based case-control study
